Release Date: 06/05/11 08:23 Summary: Woodlawn Retreatment Project - Progress Report Price Sensitive: Yes Download Document 120.16KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%